Purification and Characterization of a Novel Pentadecapeptide from Protein Hydrolysates of Cyclina sinensis and Its Immunomodulatory Effects on RAW264.7 Cells

Mar Drugs. 2019 Jan 6;17(1):30. doi: 10.3390/md17010030.

Abstract

In the present study, peptide fractions of Cyclina sinensis hydrolysates, with molecular weight (MW) < 3 kDa and highest relative proliferation rate of murine macrophage cell line RAW 264.7, were purified by a series of chromatographic purification methods, to obtain peptide fractions with immunomodulatory activity. The amino acid sequence of the peptide was identified to be Arg-Val-Ala-Pro-Glu-Glu-His-Pro-Val-Glu-Gly-Arg-Tyr-Leu-Val (RVAPEEHPVEGRYLV) with MW of 1750.81 Da, and the novel pentadecapeptide (named SCSP) was synthesized for subsequent immunomodulatory activity experiments. Results showed the SCSP enhanced macrophage phagocytosis, increased productions of nitric oxide (NO), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β), and up-regulated the protein level of inducible nitric oxide synthase (iNOS), nuclear factor κB (NF-κB), and NOD-like receptor protein 3 (NLRP3) in RAW 264.7 cells. Furthermore, the expression of inhibitor of nuclear factor κB-α (IκB-α) was down-regulated. These findings suggest that SCSP might stimulate macrophage activities by activating the NF-κB signaling pathway and can be used as a potential immunomodulatory agent in functional food or medicine.

Keywords: Cyclina sinensis; RAW264.7 cell; immunomodulatory peptides; protein hydrolysates.

MeSH terms

  • Animals
  • Bivalvia / chemistry*
  • Bivalvia / metabolism
  • Cell Line
  • Down-Regulation / drug effects
  • Immunologic Factors / chemistry*
  • Immunologic Factors / metabolism
  • Immunologic Factors / pharmacology*
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Mice
  • NF-KappaB Inhibitor alpha / metabolism
  • NF-kappa B / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Peptides / chemistry*
  • Peptides / metabolism
  • Peptides / pharmacology*
  • Phagocytosis / drug effects
  • Protein Hydrolysates / chemistry*
  • Protein Hydrolysates / metabolism
  • Protein Hydrolysates / pharmacology*
  • RAW 264.7 Cells
  • Signal Transduction / drug effects
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation / drug effects

Substances

  • Immunologic Factors
  • Interleukin-1beta
  • Interleukin-6
  • NF-kappa B
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Peptides
  • Protein Hydrolysates
  • Tumor Necrosis Factor-alpha
  • NF-KappaB Inhibitor alpha
  • Nitric Oxide
  • Nitric Oxide Synthase Type II